Chiyoda Tatsuyuki 千代田達幸

Researcher Number	40445367
Other IDs	https://orcid.org/0000-0002-8214-2242
Affiliation (Current)	2025: 慶應義塾大学, 医学部(信濃町), 講師
Affiliation (based on the past Project Information) *help	2020 – 2024: 慶應義塾大学, 医学部(信濃町), 講師 2018 – 2019: 慶應義塾大学, 医学部(信濃町), 助教 2017: 慶應義塾大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Tumor biology and related fields
Keywords	Principal Investigator トランスクリプトーム / 卵巣癌 / オルガノイド / ゲノム / 小分子RNA / 薬剤スクリーニング / オミクス / マルチオミクス / マイクロRNA / 核酸医薬 / トランスレーショナルリサーチ / 低分子RNA

Multi-omics of ovarian cancer organoids for development of novel therapeutics against drug-resistant ovarian cancersPrincipal Investigator
- Principal Investigator
  
  千代田達幸
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Keio University
Development of nucleic acid drugs based on small RNA-mRNA networks in ovarian cancer.Principal Investigator
- Principal Investigator
  
  Chiyoda Tatsuyuki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Keio University
Elucidating the mechanisms of DNA copy number aberrations in ovarian cancer - role of piRNA in ovarian cancer-Principal Investigator
- Principal Investigator
  
  Chiyoda Tatsuyuki
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Research Field
  
  Tumor biology and related fields
- Research Institution
  Keio University

All 2023 2022 2021 2020 2019

All Journal Article Presentation Book Patent

[Book] Biomarkers of Gynecological Cancers2019
- Author(s)
  Tatsuyuki Chiyoda, Ai Dozen, Keiko Saotome, Yoshiko Nanki, Daisuke Aoki
- Total Pages
  18
- Publisher
  Springer Nature
- ISBN
  9789811372957
- Data Source
  KAKENHI-PROJECT-19K18651
[Journal Article] <i>BRCA1/2</i> reversion mutations in a pan‐cancer cohort2023
- Author(s)
  Nakamura K、Hayashi H、Kawano R、Ishikawa M、Aimono E、Mizuno T、Kuroda H、Kojima Y、Niikura N、Kawanishi A、Takeshita K、Suzuki S、Ueno S、Okuwaki K、Sasaki J、Yamaguchi M、Masuda K、 Chiyoda T、Yamagami W、Okada C、Nohara S、Tanishima S、Nishihara H
- Journal Title
  
  Cancer Science
  
  Volume: 115 Issue: 2 Pages: 635-647
- DOI
  10.1111/cas.16033
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23KK0159, KAKENHI-PROJECT-23K06640, KAKENHI-PROJECT-23K21475, KAKENHI-PROJECT-23K27824
[Journal Article] Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.2023
- Author(s)
  Kitazawa S, Chiyoda T, Nakamura K, Sakai K, Yoshihama T, Nishio H, Kobayashi Y, Iwata T, Banno K, Yamagami W, Nishihara H, Aoki D.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 28 Issue: 11 Pages: 1554-1562
- DOI
  10.1007/s10147-023-02398-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16822, KAKENHI-PROJECT-23K21475
[Journal Article] <i>TP53</i> variants in p53 signatures and the clonality of STICs in RRSO samples2022
- Author(s)
  Akahane Tomoko、Masuda Kenta、Hirasawa Akira、Kobayashi Yusuke、Ueki Arisa、Kawaida Miho、Misu Kumiko、Nakamura Kohei、Nagai Shimpei、Chiyoda Tatsuyuki、Yamagami Wataru、Hayashi Shigenori、Kataoka Fumio、Banno Kouji、Sugano Kokichi、Okita Hajime、Kosaki Kenjiro、Nishihara Hiroshi、Aoki Daisuke
- Journal Title
  
  Journal of Gynecologic Oncology
  
  Volume: 33 Issue: 4
- DOI
  10.3802/jgo.2022.33.e50
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16881, KAKENHI-PROJECT-20K18174, KAKENHI-PROJECT-23K21475
[Journal Article] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer2022
- Author(s)
  Yoshihama Tomoko、Kuroda Yuka、Chiyoda Tatsuyuki、Takahashi Mio、Yoshimura Takuma、Saotome Keiko、Nanki Yoshiko、Sakai Kensuke、Kobayashi Yusuke、Yamagami Wataru、Aoki Daisuke
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 10 Pages: 1644-1650
- DOI
  10.1007/s10147-022-02212-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K16841, KAKENHI-PROJECT-23K21475
[Journal Article] 【がんゲノム医療の進歩と問題点】各臓器がん領域におけるゲノム医療の現状と課題婦人科がん2022
- Author(s)
  千代田達幸、青木大輔
- Journal Title
  
  腫瘍内科
  
  Volume: 29 (1) Pages: 33-39
- Data Source
  KAKENHI-PROJECT-23K21475
[Journal Article] Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients2022
- Author(s)
  Iwasa-Inoue N, Nomura H, Kataoka F, Chiyoda T, Yoshihama T, Nanki Y, Sakai K, Kobayashi Y, Yamagami W, Morisada T, Hirasawa A, Aoki D
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 27 Issue: 2 Pages: 441-447
- DOI
  10.1007/s10147-021-02050-3
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09297, KAKENHI-PROJECT-19K18706, KAKENHI-PROJECT-23K21475
[Journal Article] ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer2021
- Author(s)
  Kuroda Yuka、Chiyoda Tatsuyuki、Kawaida Miho、Nakamura Kohei、Aimono Eriko、Yoshimura Takuma、Takahashi Mio、Saotome Keiko、Yoshihama Tomoko、Iwasa Naomi、Sakai Kensuke、Yamagami Wataru、Nishihara Hiroshi、Aoki Daisuke
- Journal Title
  
  Gynecologic Oncology
  
  Volume: 162 Issue: 3 Pages: 679-685
- DOI
  10.1016/j.ygyno.2021.07.005
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-23K21475
[Journal Article] Estimating copy number using next-generation sequencing to determine ERBB2 amplification status2021
- Author(s)
  Nakamura Kohei、Aimono Eriko、Oba Junna、Hayashi Hideyuki、Tanishima Shigeki、Hayashida Tetsu、Chiyoda Tatsuyuki、Kosaka Takeo、Hishida Tomoyuki、Kawakubo Hirohumi、Kitago Minoru、Okabayashi Koji、Funakoshi Takeru、Okita Hajime、Ikeda Sadakatsu、Takaishi Hiromasa、Nishihara Hiroshi
- Journal Title
  
  Medical Oncology
  
  Volume: 38 Issue: 4 Pages: 36-36
- DOI
  10.1007/s12032-021-01482-1
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K18232, KAKENHI-PROJECT-19K18651
[Journal Article] A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube, or primary peritoneal cancer2021
- Author(s)
  Nanki Y, Nomura H, Iwasa N, Saotome K, Dozen A, Yoshihama T, Hirano T, Hashimoto S, Chiyoda T, Yamagami W, Kataoka F, Aoki D
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 51 Issue: 1 Pages: 54-59
- DOI
  10.1093/jjco/hyaa140
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09297, KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-20K09630, KAKENHI-PROJECT-19K18706
[Journal Article] Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing2020
- Author(s)
  Nanki Yoshiko, Chiyoda Tatsuyuki, Hirasawa Akira, Ookubo Aki, Itoh Manabu, Ueno Masaru, Akahane Tomoko, Kameyama Kaori, Yamagami Wataru, Kataoka Fumio, Aoki Daisuke.
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 1197-1197
- DOI
  10.1038/s41598-020-69488-9
- NAID
  120006880199
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09833, KAKENHI-PROJECT-20K09630, KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-17K19611
[Journal Article] Evaluating the importance of routine drainage following laparoscopic pelvic lymph node dissection for gynecological malignancies2020
- Author(s)
  Sakai Kensuke, Nakamura Masaru, Yamagami Wataru, Chiyoda Tatsuyuki, Kobayashi Yusuke, Nishio Hiroshi, Hayashi Shigenori, Nomura Hiroyuki, Kataoka Fumio, Tominaga Eiichiro, Banno Kouji, Aoki Daisuke.
- Journal Title
  
  International Journal of Gynecology & Obstetrics
  
  Volume: - Issue: 3 Pages: 438-442
- DOI
  10.1002/ijgo.13507
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K09630, KAKENHI-PROJECT-18K09298, KAKENHI-PROJECT-19K18651
[Journal Article] Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution2020
- Author(s)
  Kobayashi Yusuke、Hirasawa Akira、Chiyoda Tatsuyuki、Ueki Arisa、Masuda Kenta、Misu Kumiko、Kawaida Miho、Hayashi Shigenori、Kataoka Fumio、Banno Kouji、Kosaki Kenjiro、Aoki Daisuke
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 51 Issue: 2 Pages: 213-217
- DOI
  10.1093/jjco/hyaa173
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K16881, KAKENHI-PROJECT-17K19611, KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-20K09630
[Journal Article] Clinical implications of next generation sequencing-based panel tests for malignant ovarian tumors2020
- Author(s)
  Saotome K, Chiyoda T, Aimono E, Nakamura K, Tanishima S, Nohara S, Okada C, Hayashi H, Kuroda Y, Nomura H, Susumu N, Iwata T, Yamagami W, Kataoka F, Nishihara H, Aoki D
- Journal Title
  
  Cancer Med
  
  Volume: 9 Issue: 20 Pages: 7407-7417
- DOI
  10.1002/cam4.3383
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09297, KAKENHI-PROJECT-20K09630, KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-20K18232
[Journal Article] Uterine cervical cancer associated with obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome: A case report and review of the literature2020
- Author(s)
  Oka Emiko、Chiyoda Tatsuyuki、Iwata Takashi、Yamagami Wataru、Aoki Daisuke
- Journal Title
  
  Gynecologic Oncology Reports
  
  Volume: 34 Pages: 100645-100645
- DOI
  10.1016/j.gore.2020.100645
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18651
[Journal Article] Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis2020
- Author(s)
  Chiyoda Tatsuyuki、Sakurai Manabu、Satoh Toyomi、Nagase Satoru、Mikami Mikio、Katabuchi Hidetaka、Aoki Daisuke
- Journal Title
  
  Journal of Gynecologic Oncology
  
  Volume: 31 Issue: 5
- DOI
  10.3802/jgo.2020.31.e67
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K18651, KAKENHI-PROJECT-20H03828, KAKENHI-PROJECT-16H06277
[Journal Article] 連載 FOCUS 卵巣癌実地臨床に導入されたPARP阻害薬2019
- Author(s)
  千代田達幸, 同前愛, 早乙女啓子, 青木大輔
- Journal Title
  
  臨床婦人科産科
  
  Volume: 73 Issue: 1 Pages: 152-162
- DOI
  10.11477/mf.1409209585
- ISSN
  0386-9865, 1882-1294
- Year and Date
  2019-01-10
- Data Source
  KAKENHI-PROJECT-19K18651
[Journal Article] 特集卵巣がん征圧へのマイルストーン 7.｢PleSSision検査｣の実際2019
- Author(s)
  千代田達幸, 四十物絵理子, 早乙女啓子, 西原広史, 青木大輔
- Journal Title
  
  産婦人科の実際
  
  Volume: 68 Issue: 3 Pages: 283-288
- DOI
  10.18888/sp.0000000789
- ISSN
  0558-4728
- Year and Date
  2019-03-01
- Data Source
  KAKENHI-PROJECT-19K18651
[Journal Article] 新しいバイオマーカーとコンパニオン診断薬】各臓器がん別にみる新しいバイオマーカーとコンパニオン診断薬婦人科がん2019
- Author(s)
  千代田達幸, 黒田由香, 吉村拓馬, 南木佳子, 青木大輔
- Journal Title
  
  腫瘍内科
  
  Volume: 24 Pages: 467-472
- Data Source
  KAKENHI-PROJECT-19K18651
[Journal Article] SPHK1 is a novel target of metformin in ovarian cancer2019
- Author(s)
  Hart P, Chiyoda T (co-first author), Liu X, Weigert M, Curtis M, Chiang C, Loth R, Lastra R, McGregor S, Locasale J, Lengyel E, Romero I
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 17 Issue: 4 Pages: 870-881
- DOI
  10.1158/1541-7786.mcr-18-0409
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K18651
[Patent] 卵巣明細胞癌の治療剤2022
- Inventor(s)
  大久保　亜希、千代田　達幸、吉村　拓馬
- Industrial Property Rights Holder
  大久保　亜希、千代田　達幸、吉村　拓馬
- Industrial Property Rights Type
  特許
- Filing Date
  2022
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 再発卵巣癌に対するオラパリブ維持療法中にPDとなった症例のその後の治療成績についての検討2023
- Author(s)
  吉浜智子, 千代田達幸, 平田桃, 家谷佳那, 北澤晶子, 高橋美央, 吉村拓馬, 坂井健良, 山上亘, 青木大輔
- Organizer
  65回　婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] High-throughput drug screening using an organoid library revealed novel therapeutics and a drug target for ovarian clear cell carcinoma2023
- Author(s)
  Takuma Yoshimura, Tatsuyuki Chiyoda, Takashi Kamatani, Mio Takahashi, Kensuke Sakai, Tomoko Yoshihama, Wataru Yamagami, Tatsuhiko Tsunoda, Mamoru Tanaka, Daisuke Aoki
- Organizer
  日本産科婦人科学会　学術講演会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 【若手産婦人科医がつなぐTR,基礎研究が面白い!】難治性卵巣癌の新規治療開発を目標とした,オルガノイドライブラリを用いたTR2023
- Author(s)
  吉村拓馬, 千代田達幸, 鎌谷高志, 高橋美央, 坂井健良, 山上亘, 角田達彦, 青木大輔
- Organizer
  65回　婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] Prevalence of KRAS variants in endometrial, ovarian, and cervical tumors2023
- Author(s)
  Momo Hirata, Tatsuyuki Chiyoda, Kohei Nakamura, Takuma Yoshimura, Kensuke Sakai, Tomoko Yoshihama, Kouji Banno, Takashi Iwata, Wataru Yamagami, Hiroshi Nishihara, Mamoru Tanaka, Daisuke Aoki
- Organizer
  日本産科婦人科学会　学術講演会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 卵巣がん個別化医療の現在と展望2023
- Author(s)
  千代田　達幸
- Organizer
  第404回　東京産科婦人科学会例会
- Invited
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] ベンチワークから臨床へ繋げる婦人科がん治療に対する新たな展望　Development of novel treatment for ovarian cancer by omics analysis using organoids2023
- Author(s)
  中村康平　千代田達幸, 吉村拓馬, 四十物絵理子, 川野竜太郎, 高松玲佳, 石川麻倫, 水野孝昭, 林秀幸, 山上亘, 西原広史
- Organizer
  61回　癌治療学会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 当院における脳転移をきたした卵巣癌症例の検討2023
- Author(s)
  槌野由香里, 千代田達幸, 地坂光代, 坂巻智美, 平田桃, 高橋美央, 吉村拓馬, 坂井健良, 和田美智子, 山上亘, 田中守
- Organizer
  第407回東京産科婦人科学会例会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] ベンチワークから臨床へ繋げる婦人科がん治療に対する新たな展望　Development of novel treatment for ovarian cancer by omics analysis using organoids2023
- Author(s)
  千代田達幸, 吉村拓馬, 高橋美央, 鎌谷高志, 平田桃, 地阪光代, 坂巻智美, 和田美智子, 坂井健良, 角田達彦, 山上亘
- Organizer
  61回　癌治療学会　ワークショップ
- Invited
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 婦人科がんにおけるprecision medicine　Precision medicine in ovarian cancers2023
- Author(s)
  千代田達幸
- Organizer
  61回　癌治療学会　シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] meet the expert ovarian cancer2022
- Author(s)
  千代田　達幸
- Organizer
  卵巣癌臨床におけるPARP阻害薬
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 卵巣癌オルガノイドバンクの構築と統合オミクス解析による新規治療開発2022
- Author(s)
  千代田　達幸
- Organizer
  第74回　日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 進行卵巣癌治療選択における体腔液由来検体の細胞診断と遺伝学的検査の役割～現状と展望～進行卵巣癌治療戦略における、体腔液由来のセルブロックを用いた遺伝学的検査の有用性2022
- Author(s)
  吉浜智子, 千代田達幸, 中村康平, 四十物絵里子, 小林佑介, 西尾浩, 山上亘, 西原広史, 青木大輔
- Organizer
  第63回日本臨床細胞学会総会春期大会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 進行卵巣癌初回治療選択の考察ポイント2022
- Author(s)
  千代田達幸
- Organizer
  首都圏卵巣癌診療実践塾～薬剤治療選択の個別化を紐解く
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] ARID1A mutation is associated with a high immunogenic profile in clear cell ovarian cancer2021
- Author(s)
  Tatsuyuki Chiyoda, Daisuke Aoki
- Organizer
  ISPCM Annual meeting 2021 (International Society of Precision Cancer Medicine Virtual meeting)
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] Genomic alterations in circulating tumor DNA in patients with advanced gynecologic cancer: SCRUM-Japan MONSTAR-SCREEN2021
- Author(s)
  千代田達幸, 藤澤孝夫, 原野謙一, 大神達寛, 加藤聖子, 坂井美佳, 竹原和宏, 井平圭, 渡利英道, 竹中基記, 森重健一郎, 洞澤智至, 倉本尚美, 坂本泰理, 谷口浩也, 吉野孝之, 青木大輔
- Organizer
  第18回　日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 卵巣癌オルガノイドバンクを活用した難治性卵巣癌に対する新規治療薬の開発野澤記念研究助成金公募研究報告2021
- Author(s)
  千代田達幸
- Organizer
  第63回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 卵巣癌オルガノイドバンクを活用した　難治性卵巣癌に対する新規治療薬の開発2021
- Author(s)
  千代田　達幸
- Organizer
  第63回　日本婦人科腫瘍学会学術講演会
- Invited
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 卵巣がん薬物療法の最前線2021
- Author(s)
  千代田達幸
- Organizer
  Japan Team Oncology Program 2021 Project ECHO ONE
- Data Source
  KAKENHI-PROJECT-23K21475
[Presentation] 卵巣がん薬物療法の最前線2021
- Author(s)
  千代田　達幸
- Organizer
  Japan Team Oncology Program 2021 Project ECHO ONE
- Invited
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] ARID1A mutation is associated with a high immunogenic profile in clear cell ovarian cancer2021
- Author(s)
  Tatsuyuki Chiyoda, Daisuke Aoki
- Organizer
  ISPCM Annual meeting 2021 (International Society of Precision Cancer Medicine Virtual meeting)
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] Ovarian cancer organoids recapitulate genomic alterations of the parental tumors.2020
- Author(s)
  南木佳子, 千代田達幸, 平沢　晃, 吉村拓馬, 赤羽智子, 山上　亘, 青木大輔
- Organizer
  第79回　日本癌学会学術集会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 卵巣癌に対するBRCA1/2遺伝学的検査の適用, PARP阻害薬の適応, 効果, マネジメント2020
- Author(s)
  千代田達幸, 青木大輔
- Organizer
  第26回　日本遺伝性腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 卵巣境界悪性腫瘍に対する腹腔鏡下手術と開腹手術の比較検討2020
- Author(s)
  同前　愛, 千代田達幸, 高橋美央, 黒田由香, 吉村拓馬, 平野卓朗, 山上　亘, 青木大輔
- Organizer
  第60回　日本産科婦人科内視鏡学会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 体腔液より作成したセルブロックを用いてがん遺伝子パネル検査を行った症例の検討2020
- Author(s)
  吉浜智子, 千代田達幸, 中村康平, 四十物絵里子, 同前　愛, 平野卓朗, 黒田由香, 吉村拓馬, 小林佑介, 西尾　浩, 山上　亘, 青木大輔
- Organizer
  第59回　日本臨床細胞学会秋期大会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 再発卵巣癌のセカンドライン化学療法におけるリポソーマルドキソルビシン＋カルボプラチン療法（PLD-C）の有効性および安全性の検討2020
- Author(s)
  王　洪欣, 千代田達幸, 黒田由香, 高橋美央, 吉村拓馬, 同前　愛, 平野卓朗, 山上　亘, 青木大輔
- Organizer
  第140回　関東連合産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] Copy number alterationカウントは卵巣悪性腫瘍において進行期分類と相関する2020
- Author(s)
  千代田達幸, 早乙女啓子, 四十物絵理子, 中村康平, 谷嶋茂樹, 野原祥夫, 岡田千尋, 吉村拓馬, 黒田由香, 山上　亘, 西原広史, 青木大輔
- Organizer
  第58回　日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] 生殖細胞系列の遺伝子パネル検査をうけた、家族性の乳癌、卵巣癌が疑われた27例の検討2019
- Author(s)
  千代田達幸, 吉浜智子, 早乙女啓子, 同前愛, 南木佳子, 平野卓朗, 小林佑介, 山上亘, 野村弘行, 片岡史夫, 植木有紗, 平沢晃, 青木大輔
- Organizer
  第61回　日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] Sphingosine kinase 1 is a novel target of metformin in ovarian cancer2019
- Author(s)
  Tatsuyuki Chiyoda, Keiko Saotome, Ai Dozen, Yoshiko Nanki, Tomoko Yoshihama, Wataru Yamagami, Hiroyuki Nomura, Fumio Kataoka, Iris L. Romero, Mamoru Tanaka, Daisuke Aoki
- Organizer
  第71回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K18651
[Presentation] SPHK1 is a novel target of metformin in ovarian cancer2019
- Author(s)
  Tatsuyuki Chiyoda
- Organizer
  ISPCM Annual Meeting
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18651

1. 角田達彦 (10273468)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
2. 鎌谷高志 (90645764)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
3. SATO Kaoru

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. YAMAGAMI Wataru

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. NOMURA Hiyoyuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
6. 増田健太

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 植木有紗

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 片岡史夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
9. 赤羽智子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 吉浜智子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 中村康平

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Chiyoda Tatsuyuki 千代田 達幸

Research Projects

Research Products

Co-Researchers

Multi-omics of ovarian cancer organoids for development of novel therapeutics against drug-resistant ovarian cancersPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of nucleic acid drugs based on small RNA-mRNA networks in ovarian cancer.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidating the mechanisms of DNA copy number aberrations in ovarian cancer - role of piRNA in ovarian cancer-Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] Biomarkers of Gynecological Cancers2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] <i>BRCA1/2</i> reversion mutations in a pan‐cancer cohort2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] <i>TP53</i> variants in p53 signatures and the clonality of STICs in RRSO samples2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 【がんゲノム医療の進歩と問題点】各臓器がん領域におけるゲノム医療の現状と課題 婦人科がん2022

Author(s)

Journal Title

Data Source

[Journal Article] Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Estimating copy number using next-generation sequencing to determine ERBB2 amplification status2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube, or primary peritoneal cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Evaluating the importance of routine drainage following laparoscopic pelvic lymph node dissection for gynecological malignancies2020

Author(s)

Chiyoda Tatsuyuki 千代田達幸

[Journal Article] 【がんゲノム医療の進歩と問題点】各臓器がん領域におけるゲノム医療の現状と課題婦人科がん2022

[Journal Article] 特集卵巣がん征圧へのマイルストーン 7.｢PleSSision検査｣の実際2019

[Journal Article] 新しいバイオマーカーとコンパニオン診断薬】各臓器がん別にみる新しいバイオマーカーとコンパニオン診断薬婦人科がん2019